-
1
-
-
0034118878
-
1999 George Lyman Duff Memorial Lecture: Lipid transfer proteins. HDL metabolism, and atherogenesis
-
Tall, A. R., X. Jiang, Y. Luo, and D. Silver. 2000. 1999 George Lyman Duff Memorial Lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler. Thromb. Vasc. Biol. 20: 1185-1188.
-
(2000)
Arterioscler. Thromb. Vasc. Biol.
, vol.20
, pp. 1185-1188
-
-
Tall, A.R.1
Jiang, X.2
Luo, Y.3
Silver, D.4
-
2
-
-
0028887870
-
Molecular physiology of reverse cholesterol transport
-
Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
-
(1995)
J. Lipid Res.
, vol.36
, pp. 211-228
-
-
Fielding, C.J.1
Fielding, P.E.2
-
3
-
-
0030045883
-
High density lipoproteins and coronary heart disease
-
Barter, P. J., and K. A. Rye. 1996. High density lipoproteins and coronary heart disease. Atherosclerosis. 121: 1-12.
-
(1996)
Atherosclerosis
, vol.121
, pp. 1-12
-
-
Barter, P.J.1
Rye, K.A.2
-
4
-
-
0035924638
-
Managing the risk of atherosclerosis: The role of high-density lipoprotein
-
Libby, P. 2001. Managing the risk of atherosclerosis: the role of high-density lipoprotein. Am. J. Cardiol. 88: 3N-8N.
-
(2001)
Am. J. Cardiol.
, vol.88
-
-
Libby, P.1
-
5
-
-
0031844056
-
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
-
Bruce, C., R. A. Chouinard, Jr., and A. R. Tall. 1998. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu. Rev. Nutr. 18: 297-330.
-
(1998)
Annu. Rev. Nutr.
, vol.18
, pp. 297-330
-
-
Bruce, C.1
Chouinard Jr., R.A.2
Tall, A.R.3
-
6
-
-
0033916336
-
Role of phospholipid transfer protein in high-density lipoprotein metabolism: Insights from studies in transgenic mice
-
Van Tol, A., M. Jauhiainen, R. De Crom, and C. Ehnholm. 2000. Role of phospholipid transfer protein in high-density lipoprotein metabolism: insights from studies in transgenic mice. Int. J. Tissue React. 22: 79-84.
-
(2000)
Int. J. Tissue React.
, vol.22
, pp. 79-84
-
-
Van Tol, A.1
Jauhiainen, M.2
De Crom, R.3
Ehnholm, C.4
-
7
-
-
0035089679
-
The impact of phospholipid transfer protein (PLTP) on HDL metabolism
-
Huuskonen, J., V. M. Olkkonen, M. Jauhiainen, and C. Ehnholm. 2001. The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis. 155: 269-281.
-
(2001)
Atherosclerosis
, vol.155
, pp. 269-281
-
-
Huuskonen, J.1
Olkkonen, V.M.2
Jauhiainen, M.3
Ehnholm, C.4
-
8
-
-
0036217558
-
Phospholipid transfer protein
-
Van Tol, A. 2002. Phospholipid transfer protein. Curr. Opin. Lipidol. 13: 135-139.
-
(2002)
Curr. Opin. Lipidol.
, vol.13
, pp. 135-139
-
-
Van Tol, A.1
-
9
-
-
0033559827
-
Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
-
Jiang, X. C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
-
(1999)
J. Clin. Invest.
, vol.103
, pp. 907-914
-
-
Jiang, X.C.1
Bruce, C.2
Mar, J.3
Lin, M.4
Ji, Y.5
Francone, O.L.6
Tall, A.R.7
-
10
-
-
0033996833
-
Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins
-
Qin, S., K. Kawano, C. Bruce, M. Lin, C. Bisgaier, A. R. Tall, and X. Jiang. 2000. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J. Lipid Res. 41: 269-276.
-
(2000)
J. Lipid Res.
, vol.41
, pp. 269-276
-
-
Qin, S.1
Kawano, K.2
Bruce, C.3
Lin, M.4
Bisgaier, C.5
Tall, A.R.6
Jiang, X.7
-
11
-
-
0032812981
-
Remodelling of high density lipoproteins by plasma factors
-
Rye, K. A., M. A. Clay, and P. J. Barter. 1999. Remodelling of high density lipoproteins by plasma factors. Atherosclerosis. 145: 227-238.
-
(1999)
Atherosclerosis
, vol.145
, pp. 227-238
-
-
Rye, K.A.1
Clay, M.A.2
Barter, P.J.3
-
12
-
-
0027451376
-
High density lipoprotein conversion mediated by human plasma phospholipid transfer protein
-
Tu, A. Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 23098-23105
-
-
Tu, A.Y.1
Nishida, H.I.2
Nishida, T.3
-
13
-
-
0027469774
-
Human plasma phospholipid transfer protein causes high density lipoprotein conversion
-
Jauhiainen, M., J. Metso, R. Pahlman, S. Blomqvist, A. van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 4032-4036
-
-
Jauhiainen, M.1
Metso, J.2
Pahlman, R.3
Blomqvist, S.4
Van Tol, A.5
Ehnholm, C.6
-
14
-
-
0032987829
-
Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins
-
Wolfbauer, G., J. J. Albers, and J. F. Oram. 1999. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim. Biophys. Acta. 1439: 65-76.
-
(1999)
Biochim. Biophys. Acta
, vol.1439
, pp. 65-76
-
-
Wolfbauer, G.1
Albers, J.J.2
Oram, J.F.3
-
15
-
-
2242428907
-
Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein
-
Van Haperen, R., A. Van Tol, T. Van Gent, L. Scheek, P. Visser, A. Van Der Kamp, F. Grosveld, and R. De Crom. 2002. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J. Biol. Chem. 277: 48938-48943.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 48938-48943
-
-
Van Haperen, R.1
Van Tol, A.2
Van Gent, T.3
Scheek, L.4
Visser, P.5
Van Der Kamp, A.6
Grosveld, F.7
De Crom, R.8
-
16
-
-
0034920010
-
Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency
-
Jiang, X. C., S. Qin, C. Qiao, K. Kawano, M. Lin, A. Skold, X. Xiao, and A. R. Tall. 2001. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat. Med. 7: 847-852.
-
(2001)
Nat. Med.
, vol.7
, pp. 847-852
-
-
Jiang, X.C.1
Qin, S.2
Qiao, C.3
Kawano, K.4
Lin, M.5
Skold, A.6
Xiao, X.7
Tall, A.R.8
-
17
-
-
0036845096
-
Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion
-
Lie, J., R. De Crom, T. Van Gent, R. Van Haperen, L. Scheek, I. Lankhuizen, and A. Van Tol. 2002. Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion. J. Lipid Res. 43: 1875-1880.
-
(2002)
J. Lipid Res.
, vol.43
, pp. 1875-1880
-
-
Lie, J.1
De Crom, R.2
Van Gent, T.3
Van Haperen, R.4
Scheek, L.5
Lankhuizen, I.6
Van Tol, A.7
-
18
-
-
0037327033
-
Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis
-
Barter, P. J., H. B. Brewer, Jr., M. J. Chapman, C. H. Hennekens, D. J. Rader, and A. R. Tall. 2003. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23: 160-167.
-
(2003)
Arterioscler. Thromb. Vasc. Biol.
, vol.23
, pp. 160-167
-
-
Barter, P.J.1
Brewer Jr., H.B.2
Chapman, M.J.3
Hennekens, C.H.4
Rader, D.J.5
Tall, A.R.6
-
19
-
-
0034703057
-
Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo
-
Kawano, K., S. C. Qin, M. Lin, A. R. Tall, and X. Jiang. 2000. Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo. J. Biol. Chem. 275: 29477-29481.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 29477-29481
-
-
Kawano, K.1
Qin, S.C.2
Lin, M.3
Tall, A.R.4
Jiang, X.5
-
20
-
-
0035625680
-
Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of prebeta-high-density lipoproteins
-
Lie, J., R. de Crom, M. Jauhiainen, T. van Gent, R. van Haperen, L. Scheek, H. Jansen, C. Ehnholm, and A. van Tol. 2001. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of prebeta-high-density lipoproteins. Biochem. J. 360: 379-385.
-
(2001)
Biochem. J.
, vol.360
, pp. 379-385
-
-
Lie, J.1
De Crom, R.2
Jauhiainen, M.3
Van Gent, T.4
Van Haperen, R.5
Scheek, L.6
Jansen, H.7
Ehnholm, C.8
Van Tol, A.9
-
21
-
-
0016850021
-
Separation of plasma lipoproteins by density-gradient ultracentrifugation
-
Redgrave, T. G., D. C. Roberts, and C. E. West. 1975. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65: 42-49.
-
(1975)
Anal. Biochem.
, vol.65
, pp. 42-49
-
-
Redgrave, T.G.1
Roberts, D.C.2
West, C.E.3
-
22
-
-
0025998975
-
Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma
-
Speijer, H., J. E. Groener, E. van Ramshorst, and A. van Tol. 1991. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis. 90: 159-168.
-
(1991)
Atherosclerosis
, vol.90
, pp. 159-168
-
-
Speijer, H.1
Groener, J.E.2
Van Ramshorst, E.3
Van Tol, A.4
-
23
-
-
0035865671
-
Hydrolysis of platelet-activating factor by human serum paraoxonase
-
Rodrigo, L., B. Mackness, P. N. Durrington, A. Hernandez, and M. I. Mackness. 2001. Hydrolysis of platelet-activating factor by human serum paraoxonase. Biochem. J. 354: 1-7.
-
(2001)
Biochem. J.
, vol.354
, pp. 1-7
-
-
Rodrigo, L.1
Mackness, B.2
Durrington, P.N.3
Hernandez, A.4
Mackness, M.I.5
-
24
-
-
0029113036
-
PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme
-
Tselepis, A. D., C. Dentan, S. A. Karabina, M. J. Chapman, and E. Ninio. 1995. PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme. Arterioscler. Thromb. Vasc. Biol. 15: 1764-1773.
-
(1995)
Arterioscler. Thromb. Vasc. Biol.
, vol.15
, pp. 1764-1773
-
-
Tselepis, A.D.1
Dentan, C.2
Karabina, S.A.3
Chapman, M.J.4
Ninio, E.5
-
25
-
-
0035799373
-
Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice
-
Delsing, D. J., E. H. Offerman, W. van Duyvenvoorde, H. van Der Boom, E. C. de Wit, M. J. Gijbels, A. van Der Laarse, J. W. Jukema, L. M. Havekes, and H. M. Princen. 2001. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice. Circulation. 103: 1778-1786.
-
(2001)
Circulation
, vol.103
, pp. 1778-1786
-
-
Delsing, D.J.1
Offerman, E.H.2
Van Duyvenvoorde, W.3
Van Der Boom, H.4
De Wit, E.C.5
Gijbels, M.J.6
Van Der Laarse, A.7
Jukema, J.W.8
Havekes, L.M.9
Princen, H.M.10
-
26
-
-
0027763632
-
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
-
Mackness, M. I., S. Arrol, C. Abbott, and P. N. Durrington. 1993. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104: 129-135.
-
(1993)
Atherosclerosis
, vol.104
, pp. 129-135
-
-
Mackness, M.I.1
Arrol, S.2
Abbott, C.3
Durrington, P.N.4
-
27
-
-
0028798619
-
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
-
Watson, A. D., M. Navab, S. Y. Hama, A. Sevanian, S. M. Prescott, D. M. Stafforini, T. M. McIntyre, B. N. Du, A. M. Fogelman, and J. A. Berliner. 1995. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J. Clin. Invest. 95: 774-782.
-
(1995)
J. Clin. Invest.
, vol.95
, pp. 774-782
-
-
Watson, A.D.1
Navab, M.2
Hama, S.Y.3
Sevanian, A.4
Prescott, S.M.5
Stafforini, D.M.6
McIntyre, T.M.7
Du, B.N.8
Fogelman, A.M.9
Berliner, J.A.10
-
28
-
-
0027325516
-
Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
-
Marotti, K. R., C. K. Castle, T. P. Boyle, A. H. Lin, R. W. Murray, and G. W. Melchior. 1993. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature. 364: 73-75.
-
(1993)
Nature
, vol.364
, pp. 73-75
-
-
Marotti, K.R.1
Castle, C.K.2
Boyle, T.P.3
Lin, A.H.4
Murray, R.W.5
Melchior, G.W.6
-
29
-
-
0032917975
-
Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression
-
Plump, A. S., L. Masucci-Magoulas, C. Bruce, C. L. Bisgaier, J. L. Breslow, and A. R. Tall. 1999. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression. Arterioscler. Thromb. Vasc. Biol. 19: 1105-1110.
-
(1999)
Arterioscler. Thromb. Vasc. Biol.
, vol.19
, pp. 1105-1110
-
-
Plump, A.S.1
Masucci-Magoulas, L.2
Bruce, C.3
Bisgaier, C.L.4
Breslow, J.L.5
Tall, A.R.6
-
30
-
-
0032735679
-
Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein
-
Herrera, V. L., S. C. Makrides, H. X. Xie, H. Adari, R. M. Krauss, U. S. Ryan, and N. Ruiz-Opazo. 1999. Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nat. Med. 5: 1383-1389.
-
(1999)
Nat. Med.
, vol.5
, pp. 1383-1389
-
-
Herrera, V.L.1
Makrides, S.C.2
Xie, H.X.3
Adari, H.4
Krauss, R.M.5
Ryan, U.S.6
Ruiz-Opazo, N.7
-
31
-
-
0034644214
-
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
-
Okamoto, H., F. Yonemori, K. Wakitani, T. Minowa, K. Maeda, and H. Shinkai. 2000. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature. 406: 203-207.
-
(2000)
Nature
, vol.406
, pp. 203-207
-
-
Okamoto, H.1
Yonemori, F.2
Wakitani, K.3
Minowa, T.4
Maeda, K.5
Shinkai, H.6
-
32
-
-
0037577517
-
Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL
-
Föger, B., S. Santamarina-Fojo, R. D. Shamburek, C. L. Parrot, G. D. Talley, and H. B. Brewer, Jr. 1997. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J. Biol. Chem. 272: 27393-27400.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 27393-27400
-
-
Föger, B.1
Santamarina-Fojo, S.2
Shamburek, R.D.3
Parrot, C.L.4
Talley, G.D.5
Brewer Jr., H.B.6
-
33
-
-
0031839680
-
Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice
-
Ehnholm, S., K. W. van Dijk, B. van't Hof, A. van der Zee, V. M. Olkkonen, M. Jauhiainen, M. Hofker, L. Havekes, and C. Ehnholm. 1998. Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice. J. Lipid Res. 39: 1248-1253.
-
(1998)
J. Lipid Res.
, vol.39
, pp. 1248-1253
-
-
Ehnholm, S.1
Van Dijk, K.W.2
Van't Hof, B.3
Van Der Zee, A.4
Olkkonen, V.M.5
Jauhiainen, M.6
Hofker, M.7
Havekes, L.8
Ehnholm, C.9
-
34
-
-
0038034482
-
Membrane microdomains and vascular biology: Emerging role in atherogenesis
-
Mason, R. P., and R. F. Jacob. 2003. Membrane microdomains and vascular biology: emerging role in atherogenesis. Circulation. 107: 2270-2273.
-
(2003)
Circulation
, vol.107
, pp. 2270-2273
-
-
Mason, R.P.1
Jacob, R.F.2
-
35
-
-
0034297920
-
Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis
-
De Geest, B., D. Stengel, M. Landeloos, M. Lox, L. Le Gat, D. Collen, P. Holvoet, and E. Ninio. 2000. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis. Arterioscler. Thromb. Vasc. Biol. 20: E68-E75.
-
(2000)
Arterioscler. Thromb. Vasc. Biol.
, vol.20
-
-
De Geest, B.1
Stengel, D.2
Landeloos, M.3
Lox, M.4
Le Gat, L.5
Collen, D.6
Holvoet, P.7
Ninio, E.8
-
36
-
-
0036208796
-
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice
-
Forte, T. M., G. Subbanagounder, J. A. Berliner, P. J. Blanche, A. O. Clermont, Z. Jia, M. N. Oda, R. M. Krauss, and J. K. Bielicki. 2002. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. J. Lipid Res. 43: 477-485.
-
(2002)
J. Lipid Res.
, vol.43
, pp. 477-485
-
-
Forte, T.M.1
Subbanagounder, G.2
Berliner, J.A.3
Blanche, P.J.4
Clermont, A.O.5
Jia, Z.6
Oda, M.N.7
Krauss, R.M.8
Bielicki, J.K.9
-
37
-
-
0037162376
-
Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice
-
Tward, A., Y. R. Xia, X. P. Wang, Y. S. Shi, C. Park, L. W. Castellani, A. J. Lusis, and D. M. Shih. 2002. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation. 106: 484-490.
-
(2002)
Circulation
, vol.106
, pp. 484-490
-
-
Tward, A.1
Xia, Y.R.2
Wang, X.P.3
Shi, Y.S.4
Park, C.5
Castellani, L.W.6
Lusis, A.J.7
Shih, D.M.8
-
38
-
-
0035933117
-
Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice
-
Quarck, R., B. De Geest, D. Stengel, A. Mertens, M. Lox, G. Theilmeier, C. Michiels, M. Raes, H. Bult, D. Collen, P. Van Veldhoven, E. Ninio, and P. Holvoet. 2001. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation. 103: 2495-2500.
-
(2001)
Circulation
, vol.103
, pp. 2495-2500
-
-
Quarck, R.1
De Geest, B.2
Stengel, D.3
Mertens, A.4
Lox, M.5
Theilmeier, G.6
Michiels, C.7
Raes, M.8
Bult, H.9
Collen, D.10
Van Veldhoven, P.11
Ninio, E.12
Holvoet, P.13
-
39
-
-
0032537833
-
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
-
Shih, D. M., L. Gu, Y. R. Xia, M. Navab, W. F. Li, S. Hama, L. W. Castellani, C. E. Furlong, L. G. Costa, A. M. Fogelman, and A. J. Lusis. 1998. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 394: 284-287.
-
(1998)
Nature
, vol.394
, pp. 284-287
-
-
Shih, D.M.1
Gu, L.2
Xia, Y.R.3
Navab, M.4
Li, W.F.5
Hama, S.6
Castellani, L.W.7
Furlong, C.E.8
Costa, L.G.9
Fogelman, A.M.10
Lusis, A.J.11
-
40
-
-
0033593222
-
Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene
-
Arai, T., N. Wang, M. Bezouevski, C. Welch, and A. R. Tall. 1999. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J. Biol. Chem. 274: 2366-2371.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 2366-2371
-
-
Arai, T.1
Wang, N.2
Bezouevski, M.3
Welch, C.4
Tall, A.R.5
-
41
-
-
0037200108
-
Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E
-
Jiang, X. C., A. R. Tall, S. Qin, M. Lin, M. Schneider, F. Lalanne, V. Deckert, C. Desrumaux, A. Athias, J. L. Witztum, and L. Lagrost. 2002. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J. Biol. Chem. 277: 31850-31856.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 31850-31856
-
-
Jiang, X.C.1
Tall, A.R.2
Qin, S.3
Lin, M.4
Schneider, M.5
Lalanne, F.6
Deckert, V.7
Desrumaux, C.8
Athias, A.9
Witztum, J.L.10
Lagrost, L.11
|